These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27889915)

  • 21. Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes.
    Kim SY; Choi SY; Chao W; Volsky DJ
    J Neurochem; 2003 Dec; 87(6):1485-98. PubMed ID: 14713304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte membrane properties are altered in a rat model of developmental cortical malformation but single-cell astrocytic glutamate uptake is robust.
    Hanson E; Danbolt NC; Dulla CG
    Neurobiol Dis; 2016 May; 89():157-68. PubMed ID: 26875663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II.
    Raveendran R; Devi Suma Priya S; Mayadevi M; Steephan M; Santhoshkumar TR; Cheriyan J; Sanalkumar R; Pradeep KK; James J; Omkumar RV
    J Neurochem; 2009 Jul; 110(1):92-105. PubMed ID: 19453375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate transporter GLAST/EAAT1 directs cell surface expression of FXYD2/gamma subunit of Na, K-ATPase in human fetal astrocytes.
    Gegelashvili M; Rodriguez-Kern A; Sung L; Shimamoto K; Gegelashvili G
    Neurochem Int; 2007 Jun; 50(7-8):916-20. PubMed ID: 17316900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.
    Jen JC; Wan J; Palos TP; Howard BD; Baloh RW
    Neurology; 2005 Aug; 65(4):529-34. PubMed ID: 16116111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria.
    Ralphe JC; Segar JL; Schutte BC; Scholz TD
    J Mol Cell Cardiol; 2004 Jul; 37(1):33-41. PubMed ID: 15242733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamate transporter coupling to Na,K-ATPase.
    Rose EM; Koo JC; Antflick JE; Ahmed SM; Angers S; Hampson DR
    J Neurosci; 2009 Jun; 29(25):8143-55. PubMed ID: 19553454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.
    Vest RS; O'Leary H; Coultrap SJ; Kindy MS; Bayer KU
    J Biol Chem; 2010 Jul; 285(27):20675-82. PubMed ID: 20424167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells.
    Sandhu JK; Sikorska M; Walker PR
    J Neurosci Res; 2002 Jun; 68(5):604-14. PubMed ID: 12111850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro.
    Nakajima K; Yamamoto S; Kohsaka S; Kurihara T
    Neurosci Lett; 2008 May; 436(3):331-4. PubMed ID: 18406522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition induces neurotoxicity via dysregulation of glutamate/calcium signaling and hyperexcitability.
    Ashpole NM; Song W; Brustovetsky T; Engleman EA; Brustovetsky N; Cummins TR; Hudmon A
    J Biol Chem; 2012 Mar; 287(11):8495-506. PubMed ID: 22253441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: an in vitro study of maslinic acid.
    Qian Y; Guan T; Tang X; Huang L; Huang M; Li Y; Sun H; Yu R; Zhang F
    Eur J Pharmacol; 2011 Jan; 651(1-3):59-65. PubMed ID: 21118675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
    Apricò K; Beart PM; Crawford D; O'Shea RD
    J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases.
    Todd AC; Hardingham GE
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute exposure of L6 myotubes to cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers stimulates glucose uptake by modulating Ca2+/calmodulin-dependent protein kinase II.
    Mohankumar SK; Taylor CG; Siemens L; Zahradka P
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1321-30. PubMed ID: 22609102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes.
    Vermeiren C; Najimi M; Vanhoutte N; Tilleux S; de Hemptinne I; Maloteaux JM; Hermans E
    J Neurochem; 2005 Jul; 94(2):405-16. PubMed ID: 15998291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of calcium/calmodulin-dependent protein kinase II activity in cortical astrocytes decreases glutamate uptake and induces neurotoxic release of ATP.
    Ashpole NM; Chawla AR; Martin MP; Brustovetsky T; Brustovetsky N; Hudmon A
    J Biol Chem; 2013 May; 288(20):14599-14611. PubMed ID: 23543737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia.
    Beschorner R; Simon P; Schauer N; Mittelbronn M; Schluesener HJ; Trautmann K; Dietz K; Meyermann R
    Histopathology; 2007 Jun; 50(7):897-910. PubMed ID: 17543080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylmercury alters the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.
    Mutkus L; Aschner JL; Syversen T; Aschner M
    Biol Trace Elem Res; 2005 Dec; 107(3):231-45. PubMed ID: 16286679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric modulation of an excitatory amino acid transporter: the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain.
    Abrahamsen B; Schneider N; Erichsen MN; Huynh TH; Fahlke C; Bunch L; Jensen AA
    J Neurosci; 2013 Jan; 33(3):1068-87. PubMed ID: 23325245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.